378 related articles for article (PubMed ID: 15376304)
21. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
22. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
Botha JF; Thompson E; Gilroy R; Grant WJ; Mukherjee S; Lyden ER; Fox IJ; Sudan DL; Shaw BW; Langnas AN
Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
[TBL] [Abstract][Full Text] [Related]
23. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
[TBL] [Abstract][Full Text] [Related]
24. Are posttransplantation protocol liver biopsies useful in the long term?
Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
Schmeding M; Neumann UP; Puhl G; Bahra M; Neuhaus R; Neuhaus P
Liver Transpl; 2007 May; 13(5):687-92. PubMed ID: 17457911
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
[TBL] [Abstract][Full Text] [Related]
27. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
Sreekumar R; Gonzalez-Koch A; Maor-Kendler Y; Batts K; Moreno-Luna L; Poterucha J; Burgart L; Wiesner R; Kremers W; Rosen C; Charlton MR
Hepatology; 2000 Nov; 32(5):1125-30. PubMed ID: 11050065
[TBL] [Abstract][Full Text] [Related]
28. A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.
do O NT; Eurich D; Schmitz P; Schmeding M; Heidenhain C; Bahra M; Trautwein C; Neuhaus P; Neumann UP; Wasmuth HE
Liver Transpl; 2012 Mar; 18(3):298-304. PubMed ID: 22139994
[TBL] [Abstract][Full Text] [Related]
29. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4.
Wali MH; Heydtmann M; Harrison RF; Gunson BK; Mutimer DJ
Liver Transpl; 2003 Aug; 9(8):796-804. PubMed ID: 12884191
[TBL] [Abstract][Full Text] [Related]
30. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
31. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
Samonakis DN; Cholongitas E; Thalheimer U; Kalambokis G; Quaglia A; Triantos CK; Mela M; Manousou P; Senzolo M; Dhillon AP; Patch D; Burroughs AK
Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
[TBL] [Abstract][Full Text] [Related]
32. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
[TBL] [Abstract][Full Text] [Related]
33. All liver recipients benefit from the protocol 10-year liver biopsies.
Sebagh M; Rifai K; Féray C; Yilmaz F; Falissard B; Roche B; Bismuth H; Samuel D; Reynès M
Hepatology; 2003 Jun; 37(6):1293-301. PubMed ID: 12774007
[TBL] [Abstract][Full Text] [Related]
34. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.
Hanouneh IA; Feldstein AE; McCullough AJ; Miller C; Aucejo F; Yerian L; Lopez R; Zein NN
Liver Transpl; 2008 Sep; 14(9):1287-93. PubMed ID: 18756451
[TBL] [Abstract][Full Text] [Related]
35. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index.
Benlloch S; Berenguer M; Prieto M; Rayón JM; Aguilera V; Berenguer J
Liver Transpl; 2005 Apr; 11(4):456-62. PubMed ID: 15776403
[TBL] [Abstract][Full Text] [Related]
36. The impact of nonalcoholic fatty liver disease and the metabolic syndrome on progression of fibrosis in patients with recurrent HCV after liver transplantation.
Mindikoglu AL; Regev A; Casanova-Romero PY; Bejarano PA; Martinez EJ; Tzakis AG; Schiff ER
Transplant Proc; 2006 Jun; 38(5):1440-4. PubMed ID: 16797327
[TBL] [Abstract][Full Text] [Related]
37. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
Testa G; Crippin JS; Netto GJ; Goldstein RM; Jennings LW; Brkic BS; Brooks BK; Levy MF; Gonwa TA; Klintmalm GB
Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
[TBL] [Abstract][Full Text] [Related]
38. Diabetes and hepatic oxidative damage are associated with hepatitis C progression after liver transplantation.
Cotler SJ; Kallwitz E; TenCate V; Bhushan A; Berkes J; Benedetti E; Layden-Almer J; Layden TJ; Valyi-Nagy T; Guzman G
Transplantation; 2007 Sep; 84(5):587-91. PubMed ID: 17876270
[TBL] [Abstract][Full Text] [Related]
39. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
40. Liver transplantation for HCV-associated liver cirrhosis: predictors of outcomes in a population with significant genotype 3 and 4 distribution.
Zekry A; Whiting P; Crawford DH; Angus PW; Jeffrey GP; Padbury RT; Gane EJ; McCaughan GW;
Liver Transpl; 2003 Apr; 9(4):339-47. PubMed ID: 12682883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]